Ch 1Cells & Genomes
Cells are bounded compartments separating "self" from environment. The simplest cells (Mycoplasma, ~0.3 μm) approach the theoretical minimum genome (~500 essential genes) needed for autonomous life. Bacterial cells (~1 μm) lack membrane-bound organelles. Eukaryotic cells (~10 μm) compartmentalize functions into organelles, allowing specialization + larger genomes.
Endosymbiotic theory (Margulis 1967): mitochondria + chloroplasts evolved from free-living bacteria engulfed by ancestral eukaryotes. Evidence: their own circular genomes, 70S bacterial-style ribosomes, double membranes (host + bacterial), bacterial-style protein synthesis machinery, division by binary fission. Mitochondria most closely related to Rickettsiales (α-proteobacteria); chloroplasts to cyanobacteria.
Model organisms: E. coli (genetics workhorse), S. cerevisiae (eukaryotic genetics), C. elegans (development; Karen Kim Guisbert's organism), Drosophila (genetics + development), zebrafish (vertebrate development), mouse (mammalian genetics), human cell lines (HeLa, HEK293, MCF-7).
Ch 3Proteins
20 standard amino acids vary in side chain (R-group): hydrophobic (Ala, Val, Leu, Ile, Phe), polar uncharged (Ser, Thr, Tyr, Cys), positive (Lys, Arg, His), negative (Asp, Glu), special (Gly, Pro). Proteins fold to bury hydrophobic residues + expose polar ones to water — the hydrophobic effect drives folding.
Four levels of structure: 1° sequence (peptide bonds, N→C); 2° α-helix + β-sheet (backbone H-bonds); 3° 3D fold of one chain; 4° multi-subunit assembly. Domains (~50–200 AA) are independent folding units, often corresponding to functions.
Misfolding is dangerous. Cells deploy chaperones (Hsp70, Hsp90, GroEL/GroES) to prevent aggregation. Damaged proteins are tagged with polyubiquitin (Lys48-linked) and degraded by the 26S proteasome. Eric Guisbert at UNomaha studies the heat shock response — chaperone induction during stress.
Allostery: effector binding at non-active site changes conformation + activity. Enables on/off + graded regulation. Hemoglobin's cooperative O₂ binding (T ↔ R state transition) is the classic example.
Ch 5DNA Replication + Repair
Replication starts at origins (oriC in E. coli, multiple in eukaryotes), proceeds bidirectionally. Helicase unwinds DNA; SSB coats single-stranded DNA; primase lays RNA primers; DNA pol III (bacterial) extends 5'→3'; leading strand synthesized continuously, lagging strand in Okazaki fragments later joined by ligase.
Telomerase is an RNP with intrinsic RNA template that extends 3' overhangs of telomeres. Active in germ cells + many cancers; usually OFF in somatic cells → telomere shortening with each division → senescence (Hayflick limit ~50 divisions). ~85% of cancers reactivate telomerase via TERT promoter mutations.
- Mismatch repair (MMR) — corrects misincorporations after replication. MutSα recognizes mismatch; MutLα + Exo1 excise; pol δ resynthesizes. Defects → Lynch syndrome (HNPCC).
- Base excision repair (BER) — small base damage (oxidation, deamination). Glycosylase removes damaged base; AP endonuclease cuts; gap filled.
- Nucleotide excision repair (NER) — bulky lesions (UV pyrimidine dimers). XP proteins; defects → xeroderma pigmentosum, severe UV sensitivity.
- Homologous recombination (HR) — error-free DSB repair using sister chromatid template. BRCA1, BRCA2, Rad51. Defects → breast/ovarian cancer.
- NHEJ — error-prone end joining (Ku70/80, DNA-PKcs, Lig4). Default in G1.
Ch 11Membrane Transport
Channels form pores; once open, transport is fast (~10⁸ ions/sec) but always passive (down gradient). Channels can be ungated (water — aquaporin), voltage-gated (Na_v in neurons), ligand-gated (nicotinic ACh receptor), mechanically gated (cochlear hair cells).
Carriers (transporters) bind solute, undergo conformational cycle, release on other side. Slower than channels (~10⁴/sec). Either passive (GLUT family — facilitated diffusion) or active.
Active transport: primary uses ATP directly (Na⁺/K⁺-ATPase pumps 3 Na⁺ out + 2 K⁺ in per ATP — sets up the resting potential and gradients exploited by neurons + secondary transport). Secondary couples downhill ion gradient to uphill solute movement (Na⁺/glucose symport in intestine, Na⁺/H⁺ antiport).
Voltage-gated channels drive action potentials. The Hodgkin-Huxley model (1952 Nobel) describes Na⁺ + K⁺ kinetics. Patch clamp (Sakmann/Neher 1991 Nobel) records single-channel currents — molecular basis of bioelectricity.
Ch 12Intracellular Compartments + Protein Sorting
Co-translational ER import: signal peptide emerges from ribosome; SRP binds; halts translation; SRP-receptor at ER docks ribosome; translocon Sec61 opens; polypeptide threads through; signal peptidase cleaves signal. Then folding + N-glycosylation in ER lumen.
NLS (nuclear localization signal — Lys/Arg-rich) recognized by importin α/β; transit through nuclear pore complex; RanGTP releases cargo in nucleus. Mitochondrial matrix targeting sequence (positively charged amphipathic helix) binds TOM (outer) + TIM23 (inner) translocases — POST-translational. Peroxisomal targeting signal PTS1 (C-terminal SKL).
ERAD (ER-associated degradation): misfolded ER proteins retrotranslocated to cytosol → ubiquitinated → proteasome. UPR (unfolded protein response): IRE1 + PERK + ATF6 sensors → halt translation, upregulate chaperones, expand ER → if unresolved → CHOP-mediated apoptosis.
Ch 15Cell Communication
Receptor classes: cell-surface (GPCR, RTK, ligand-gated channel, integrin) vs intracellular (nuclear receptors for steroids, thyroid hormone — direct DNA binding via zinc-finger or related domains).
GPCR signaling: ~800 GPCRs in humans (~30% of FDA drug targets). Ligand → heterotrimeric G protein → Gα-GTP → effectors (adenylate cyclase makes cAMP → PKA; PLCβ makes IP₃ + DAG → Ca²⁺ + PKC). Desensitization by GRK + β-arrestin (clathrin endocytosis).
RTK signaling: ~60 RTKs in humans (EGFR, insulin R, VEGFR, etc.). Ligand → dimerization → trans-autophosphorylation of cytoplasmic tail Tyr → SH2/PTB-domain adaptor proteins (Grb2/SOS for Ras pathway; PI3K for PI3K-AKT pathway).
Wnt/β-catenin: Wnt → Frizzled → Dishevelled → inhibits APC/GSK3/axin destruction complex → β-catenin to nucleus → TCF/LEF target genes. APC mutated in colon cancer (familial adenomatous polyposis + sporadic).
Notch (juxtacrine): Delta/Jagged on neighbor → ADAM10 + γ-secretase cleave Notch → NICD enters nucleus → CSL → HES/HEY genes. Lateral inhibition in development.
TGF-β/SMAD: receptor Ser/Thr kinase phosphorylates R-SMADs → bind co-SMAD4 → nucleus → target genes.
Ch 16Cytoskeleton
Actin (microfilaments, 7 nm): G-actin (ATP-bound) polymerizes to F-actin. Polar (+ end fast-growing, − end slow). Treadmilling at steady state. Nucleators: Arp2/3 (branched networks → lamellipodia), formins (linear unbranched → stress fibers, contractile ring). Motor: myosin family (II = muscle + cytokinesis; V = vesicle transport).
Microtubules (25 nm): αβ-tubulin dimers polymerize with GTP. 13 protofilaments. Polar (− at MTOC/centrosome, + outward). Dynamic instability: GTP cap stabilizes growth; cap loss → catastrophe (rapid shrinkage); rescue restarts growth. Motors: kinesin (+ end, anterograde) and dynein (− end, retrograde). Drugs: colchicine + vincristine bind tubulin → block polymerization (anti-cancer); paclitaxel (Taxol) stabilizes MT → blocks depolymerization (anti-cancer).
Intermediate filaments (10 nm): coiled-coil dimers → tetramers → 8-tetramer staggered units → filaments. Non-polar, no motors, very stable. Pure mechanical scaffolds. Examples: keratins (epithelia), vimentin (mesenchymal), nuclear lamins (nuclear envelope), desmin (muscle), GFAP (astrocytes).
Cilia + flagella: 9+2 axoneme (9 outer doublets + 2 central singlets). Dynein arms drive sliding of doublets → bending. Defects → primary ciliary dyskinesia (Kartagener syndrome). Primary cilium = single immotile cilium found on most vertebrate cells; sensory + signaling (Hedgehog).
Ch 17Cell Cycle + Programmed Cell Death
Phases: G1 (growth, decision) → S (DNA replication) → G2 (pre-mitotic) → M (mitosis + cytokinesis); G0 = quiescent.
Cyclin/CDK pairings: D + CDK4/6 (G1 → R point), E + CDK2 (G1/S), A + CDK2 (S), A + CDK1 (G2), B + CDK1 (M).
Restriction point (R) in late G1: Rb hyperphosphorylated → releases E2F TF → S-phase genes transcribed. p53/p21 can block this. In quiescent cells, Rb hypophosphorylated, E2F sequestered.
p53 ("guardian of genome"): DNA damage → ATM/ATR → p53 stabilized (otherwise MDM2 ubiquitinates it) → induces p21 (CDK inhibitor → G1 arrest) + pro-apoptotic genes (Bax, Puma). p53 mutated in ~50% of human cancers.
SAC (Spindle Assembly Checkpoint): unattached kinetochores generate Mad2-MCC → blocks APC/C-Cdc20 → securin not degraded → separase inactive → cohesin holds sister chromatids. Once all attached, MCC dissolves → APC/C active → securin destroyed → separase cleaves cohesin → anaphase. Cyclin B also degraded → CDK1 inactive → mitotic exit.
Other PCD modes: pyroptosis (caspase-1/4/5/11 → gasdermin D pore — inflammatory; Chivero focus in NEUR 1520), necroptosis (RIPK1-RIPK3-MLKL), ferroptosis (iron-dependent lipid peroxidation), autophagy-dependent death.
Ch 19Cell Junctions, Adhesion, ECM — JOHNSON FOCUS
Tight junctions (zonula occludens): apical seal between epithelial cells. Strands of claudins + occludin form paracellular barrier. Cytoplasmic adaptor ZO-1 links to actin. Defines apical/basolateral polarity. Different claudins have different permeabilities — Cld-2 leaky in kidney; Cld-5 tight in brain endothelium (BBB).
Adherens junctions (zonula adherens): belt-like, just below tight junctions. E-cadherin (epithelia) makes Ca²⁺-dependent homophilic bonds with E-cadherin on neighbor cells. Cytoplasmic tail binds β-catenin → α-catenin → actin filaments. Critical for tissue integrity. Johnson's specialty.
Desmosomes (macula adherens): spot-welds for mechanical resistance. Cadherin family desmocollin + desmoglein → cytoplasmic plakoglobin + desmoplakin → keratin intermediate filaments. Skin + cardiac muscle. Pemphigus = autoantibodies vs Dsg → skin blistering.
Gap junctions: communicating channels between cells. Connexin hexamer = connexon (hemichannel). Two connexons across the gap form the channel. Permeability ~1 kDa (ions, cAMP, IP₃). Closed by acid pH, high cytoplasmic Ca²⁺, voltage, phosphorylation. Cardiac myocytes coupled via gap junctions for synchronized contraction. Johnson's specialty.
Hemidesmosomes: cell-to-ECM (basal lamina) anchors. Integrin α6β4 binds laminin in basal lamina; cytoplasmic side connects to keratin IFs (NOT actin like other integrin junctions).
Focal adhesions: another cell-to-ECM junction. Integrins (α/β heterodimers) bind ECM proteins → cytoplasmic talin/vinculin/paxillin → actin. Mechanosensing + signaling (FAK, Src). Critical in cell migration.
- Epithelial cell receives EMT signal (TGF-β, Wnt, Notch, hypoxia).
- EMT transcription factors (Snail, Slug, ZEB1/2, Twist) upregulated.
- E-cadherin DOWN, N-cadherin UP (cadherin switch).
- Tight junctions disassemble; cell loses apico-basal polarity.
- β-catenin re-localizes to nucleus → drives Wnt target genes.
- Cytoskeleton remodels (vimentin instead of keratin IFs).
- Cell becomes migratory, invasive, mesenchymal-shaped.
- Critical in development (gastrulation, neural crest), wound healing, AND cancer metastasis.
ECM: collagen (most abundant; 28 types in humans; type IV in basal lamina), elastin (skin, blood vessels, lungs), proteoglycans (heparan + chondroitin sulfate; massive carbohydrate-protein complexes), fibronectin (ECM scaffold + integrin ligand), laminin (basal lamina). MMPs (matrix metalloproteinases) remodel ECM — normal tissue turnover + cancer invasion.
Ch 20Cancer
10 Hallmarks of Cancer (Hanahan + Weinberg 2011 update):
- Sustained proliferative signaling (oncogenic Ras, EGFR amplification).
- Evading growth suppressors (loss of Rb, p53).
- Resisting cell death (Bcl-2 overexpression, p53 loss).
- Replicative immortality (telomerase reactivation).
- Inducing angiogenesis (VEGF).
- Activating invasion + metastasis (EMT, MMPs).
- Reprogramming energy metabolism (Warburg effect — aerobic glycolysis).
- Evading immune destruction (PD-L1).
- Tumor-promoting inflammation.
- Genome instability + mutation (mismatch repair defects, BRCA loss).
Oncogenes are gain-of-function mutated proto-oncogenes; dominant. Ras (~30% of human cancers) is the most common. Myc amplified or translocated (Burkitt lymphoma t(8;14)). EGFR mutated/amplified in lung adenocarcinoma. BCR-ABL from t(9;22) in CML.
Tumor suppressors are loss-of-function (Knudson 2-hit). p53 (most-mutated, ~50%), Rb (retinoblastoma), APC (FAP/sporadic colon), PTEN (multiple), BRCA1/2 (breast/ovarian), VHL (renal cell carcinoma).
Metastasis cascade: local invasion (EMT, MMP-mediated basal lamina breach) → intravasation → circulation survival → extravasation → colonization at distant site. Most cancer deaths from metastases, not primary tumor.
Modern therapies: targeted (Imatinib for BCR-ABL CML; Trastuzumab for HER2+ breast; PARP inhibitors for BRCA-deficient), immunotherapy (anti-PD-1/PD-L1 checkpoint inhibitors — Pembrolizumab, Nivolumab; CAR-T cells), chemo (DNA-damaging — cisplatin, doxorubicin; antimetabolites — methotrexate; mitotic — Taxol).
Ch 21Lab Techniques (Northam's lab block)
Mammalian cell culture: keep cells in incubator at 37°C, 5% CO₂ (buffers bicarbonate medium pH), humidified. Sterile work in BSC (biosafety cabinet). Common medium: DMEM or RPMI + 10% FBS (fetal bovine serum) + antibiotics. Trypsinize to detach adherent cells; passage at 70–90% confluence.
Common cell lines: HeLa (cervical cancer, Henrietta Lacks 1951 — first immortal line), HEK293 (embryonic kidney; "easily transfectable"), NIH-3T3 (mouse fibroblast), MCF-7 (breast cancer), U2OS (osteosarcoma).
Transfection: lipofection (cationic lipid vesicles deliver DNA), electroporation (transient electric pulses), viral vectors (lentivirus integrates stably). Selection markers: G418/neomycin, puromycin, hygromycin, blasticidin.
- Fix cells (paraformaldehyde 4% — cross-links proteins).
- Permeabilize (Triton X-100 or saponin).
- Block (BSA 1–5% or normal serum 10%).
- Primary antibody (anti-target, raised in mouse/rabbit/etc.; 1–2 hr).
- Wash.
- Fluorescent secondary antibody (anti-mouse/anti-rabbit; 1 hr).
- Wash.
- DAPI (DNA counterstain) + mounting medium with anti-fade.
- Image on confocal/widefield.
Western blot: lyse cells → SDS-PAGE → transfer to PVDF/nitrocellulose → block → primary Ab → HRP-secondary Ab → ECL detection. Quantitative protein detection.
RT-qPCR: RNA → cDNA (reverse transcriptase) → qPCR with SYBR Green or TaqMan. ΔΔCt normalizes target Ct to housekeeping (β-actin, GAPDH, 18S) AND to control sample. Fold-change = 2^(−ΔΔCt).
FACS (flow cytometry / sorting): cells in suspension flow past laser; light scatter (size + granularity) + fluorescence (markers) detected. Sort populations of interest. Used for cell-cycle analysis (PI/DAPI), apoptosis (Annexin V/PI), surface marker phenotyping.
CRISPR-Cas9: sgRNA targets Cas9 nuclease to specific genomic site → blunt double-strand break ~3 bp upstream of PAM (NGG). Repair: NHEJ → small indels → frameshift knockout. HDR with donor template → precise edit/knockin. CRISPRi (dCas9-KRAB) represses; CRISPRa (dCas9-VP64) activates.
siRNA: 21-nt dsRNA loaded into RISC; guide strand pairs to target mRNA → cleavage. Transient knockdown (need re-delivery). shRNA: stable expression from plasmid → continuous knockdown.
Microscopy: bright-field (basic), phase contrast (unstained live cells), DIC (3D-shaded), fluorescence (multiplex with antibodies + fluorescent proteins like GFP), confocal (optical sectioning), super-resolution (STED, STORM, PALM — <100 nm), two-photon (deep tissue), light sheet (gentle, fast 3D), TEM (transmission EM, ~0.1 nm), SEM (scanning EM, surface).
FRAP (Fluorescence Recovery After Photobleaching): bleach a region of fluorescent protein → measure recovery → quantify diffusion + turnover.
FRET: donor fluorophore → acceptor energy transfer when 1–10 nm apart. Reports protein-protein interactions or conformational changes.